DeSantis Damon (CIK 1889279) reported 7 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-15). Recent activity: Buy CELH (20,000 shares), Buy CELH (16,000 shares), Buy INBP (9.0M shares), Buy INBP (2.2M shares), Buy INBP (1.4M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-15 | Celsius Holdings, Inc. (CELH) | Director | Buy | 20,000 | $553,000 |
| 2026-09-15 | Celsius Holdings, Inc. (CELH) | Director | Buy | 16,000 | $447,200 |
| 2026-04-17 | INTEGRATED BIOPHARMA INC (INBP) | Director | Buy | 9.0M | $0 |
| 2026-04-17 | INTEGRATED BIOPHARMA INC (INBP) | Director | Buy | 2.2M | $0 |
| 2026-03-25 | INTEGRATED BIOPHARMA INC (INBP) | Director | Buy | 1.4M | $0 |
| 2026-03-25 | INTEGRATED BIOPHARMA INC (INBP) | Director | Buy | 7,392 | $0 |
| 2026-03-03 | Celsius Holdings, Inc. (CELH) | Director | Buy | 2,611 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-15